PAX2 is the most sensitive and specific marker that can distinguish MAs from ovarian endometrioid carcinoma and can be used as a first-line marker with ER/PR and GATA3/TTF1 (75). This evidence concerns the gene TTF1 and ovarian endometrioid carcinoma.